As novel viruses and pathogens appear across the globe, you need an experienced partner with the capabilities to help you ensure your product meets regulatory requirements for label claims.

Element is at the forefront of disinfectant efficacy testing against SARS-CoV-2 and its variants, which are the causative agents of COVID-19. Since the pandemic began, for the most prominent developers, manufacturers and marketers of infection control products, Element has conducted countless tests to evaluate the effectiveness of their medical, industrial, and consumer disinfectants and support regulated claims against SARS-CoV-2. 

Element has access to the initial SARS-CoV-2 (Wuhan) strain and the U.K. (B.1.1.7) variant, which are the most prevalent strains in the United States, to support clients' disinfectant efficacy label claims. 

With one of only a few GLP-compliant Biosafety Level 3 (BSL-3) laboratories in the United States, we have been instrumental in helping our clients combat this public health crisis. Our expanded COVID-19 variant testing services and enhanced BSL-3 capabilities have ensured Element remains well-positioned to continue helping our partners to fight the current pandemic and future public health threats.

For more information or to request a custom testing quote, contact us. 

Request a quote or speak with one of our antimicrobial experts

Request a quote or speak with one of our antimicrobial experts